The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.

CONCLUSION: Postoperative hormone therapy with DRSP/E2 in EC survivors did not increase recurrence or the death rate. PMID: 30022635 [PubMed - as supplied by publisher]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research